Tenet Healthcare Corporation
Tenet Healthcare Corporation Q2 FY26 Results — Earnings Call Analysis
Q2 FY26 earnings call: what management said on revenue, margins and capex.
What the Q2 FY26 call signalled
1 of 3 strong
The short version
- Hospital segment expects a 10% normalized year-over-year adjusted EBITDA growth in 2026, supported by expense management and growth initiatives. - Tenet Healthcare reaffirmed its full-year 2026 guidance, expecting adjusted EBITDA to grow approximately 10% year-over-year at the midpoint, excluding non-recurring items and the impact of exchange premium tax credit expirations.
From Tenet Healthcare Corporation's Q2 FY26 earnings-call transcript · updated 29 May 2026.
Revenue & Sales Performance
- Hospital segment expects a 10% normalized year-over-year adjusted EBITDA growth in 2026, supported by expense management and growth initiatives.
- USPI showed a 5.3% increase in same-facility system-wide revenues in Q1 2026, with net revenue per case up 5.6%, though volumes were slightly down 0.3%.
- Growth fueled by investments in technology, AI-related capabilities, recruitment, and retention improvements.
- Focus on higher acuity service offerings and new surgical and emergency-related programs to drive organic growth.
- Active share repurchases expected to continue, capitalizing on current valuation multiples.
2 more points from Tenet Healthcare Corporation's call on revenue
Create a free account to keep reading this call
Profitability & Margins
See what Tenet Healthcare Corporation said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- Continued capital investments to grow USPI through M&A, targeting $250 million annual USPI M&A spend.
- Investments in key hospital growth opportunities focused on higher acuity service offerings.
- Ongoing investments in technology to enable growth and streamline operations, including AI-related capabilities and third-party EMR integrated solutions.
- Pilot programs for ambient scribe, automated discharge summaries, and autonomous professional fee coding to improve clinician productivity.
- Increased back-office AI automation to improve productivity and reduce costs, such as doubling productivity of Conifer analytics team.
2 more points from Tenet Healthcare Corporation's call on capex
Create a free account to keep reading this call
Fundraising & Capital Structure
See what Tenet Healthcare Corporation said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
Continue your research
Others in Health Care Providers and Services this season
- BrightSpring Health Services, Inc. (Q2 FY26)
BrightSpring Health Services, Inc. Q2 FY26 quarterly results analysis. Pharmacy Solutions expected to see balanced sequential revenue and EBITDA growth througho
- DaVita Inc. (Q2 FY26)
DaVita Inc. Q2 FY26 quarterly results analysis. Treatment volume guidance raised from flat to 25-50 basis points growth for 2026, driven by better underlying pe
- Guardant Health, Inc. (Q2 FY26)
Guardant Health, Inc. Q2 FY26 quarterly results analysis. Sales team started this year with ~300 reps; incremental gross profit will be reinvested in expanding
- Quest Diagnostics Incorporated (Q2 FY26)
Quest Diagnostics Incorporated Q2 FY26 quarterly results analysis. Q1 2026 organic volume growth was strong at 10.8%, with total volume growth at 10.9%. Market
Potential multibaggers · Q2 FY27
This quarter's potential multibaggers
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
Tenet Healthcare Corporation and 15K+ more earnings calls,
for less than your morning chai
a day
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Tenet Healthcare Corporation Q2 FY26 results?
- Hospital segment expects a 10% normalized year-over-year adjusted EBITDA growth in 2026, supported by expense management and growth initiatives. - Tenet Healthcare reaffirmed its full-year 2026 guidance, expecting adjusted EBITDA to grow approximately 10% year-over-year at the midpoint, excluding non-recurring items and the impact of exchange premium tax credit expirations.
What is Tenet Healthcare Corporation share price analysis?
Tenet Healthcare Corporation currently shows a below-average growth signal. The stock trades at a P/E of 9.2 with a market cap of $14,919. Investors should review the full earnings analysis for detailed insights.
Is Tenet Healthcare Corporation planning capital expenditure?
- Continued capital investments to grow USPI through M&A, targeting $250 million annual USPI M&A spend.
Keep Tenet Healthcare Corporation on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.